Gilbert M. Rishton
Corporate Officer/Principal en CARDAX, INC. .
Perfil
Dr. Gilbert M.
Rishton is a Member-Scientific Advisory Board at Cardax, Inc. Dr. Rishton was previously employed as a Chief Medicinal Chemistry Advisor by Cognition Therapeutics, Inc., a Chemistry Manager by Amgen, Inc., and a Chief Science Officer by Cardax Pharmaceuticals, Inc. He also served on the board at Channel Islands Alzheimer's Institute.
He received his undergraduate degree from the University of Rhode Island and a doctorate degree from Florida State University.
Cargos activos de Gilbert M. Rishton
| Empresas | Cargo | Inicio |
|---|---|---|
| CARDAX, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Gilbert M. Rishton.
| Empresas | Cargo | Fin |
|---|---|---|
| Channel Islands Alzheimer's Institute | Fundador | 01/12/2010 |
| AMGEN INC. | Corporate Officer/Principal | - |
| COGNITION THERAPEUTICS, INC. | Fundador | - |
Cardax Pharmaceuticals, Inc.
 Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Director Técnico/Científico/I+D | - |
Formación de Gilbert M. Rishton.
| University of Rhode Island | Undergraduate Degree |
| Florida State University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| CARDAX, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Health Technology |
| Channel Islands Alzheimer's Institute |
- Bolsa de valores
- Insiders
- Gilbert M. Rishton
